Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices 11471 

Targeting, Coordinating, and Reporting 

Needed to Enhance Program Effectives. 

One of the findings encouraged the two 

agencies ‘‘to determine the extent to 

which veterans’ employment outcomes 

result from program participation. . .’’ 

As a result of the GAO 

recommendations, a Joint Work Group 

was directed to establish and 

standardize processes to ensure disabled 

veterans participating in the Chapter 31 

program achieve the ultimate goal of 

successful career transition and suitable 

employment after the provision of Labor 

Market Information and employment 

services from the Jobs for Veterans State 

Grant recipients. The Joint Work Group 

refined processes and strengthened the 

team approach to serving these disabled 

veterans. 

The Vocational Rehabilitation & 

Employment (Chapter 31) Tracking 

Report (VETS 201) is designed to 

respond to the GAO finding by 

compiling information on disabled 

veterans jointly served by the VA, VETS 

and Jobs for Veterans State Grant 

recipients. All partners agree to share 

information exclusively to facilitate job 

development and placement services for 

participating veterans. The information 

is collected only with documented 

consent from veterans in accordance 

with the Privacy Act of 1974 and other 

applicable regulations and each agency 

will provide practical and appropriate 

safeguards to protect Personally 

Identifiable Information in accordance 

with applicable regulations and laws, 

including the Americans with 

Disabilities Act of 1990, the 

Rehabilitation Act of 1973 and 

reauthorizations, and title VII of the 

Civil Rights Act of 1964. 

The information is collected by the 

Jobs for Veterans State grant recipient 

and submitted to the state Director for 

Veterans’ Employment and Training 

(DVET) once per Federal fiscal quarter. 

The results are shared between VETS 

and VA VR&E. 

Estimated Annual Burden: VETS 201: 

456 Hours. 

Estimated Average Burden Per 

Respondent: VETS 201 (Proposed): 2 

Hours, Range 1–3 Hours. 

Frequency of Response: Quarterly. 

Estimated Number of Respondents: 

VETS 201: 57. 

Total Annualized Capital/startup 

costs: $0. 

Total Initial Annual Costs: $0. 

Comments submitted in response to 

this notice will be summarized and 

included in the agency’s request for 

OMB approval of the information 

collection request. Comments will 

become a matter of public record. 

Dated in Washington, DC, this 23rd day of 

February 2015. 

Ralph Charlip, 

Deputy Assistant Secretary. 

[FR Doc. 2015–04357 Filed 3–2–15; 8:45 am] 

BILLING CODE 4510–79–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2015–0020] 

Information Collection: NRC Request 

for Information Concerning Patient 

Release Practices 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Proposed information 

collection; request for comment. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) invites public 

comment on this proposed collection of 

information. The information collection 

is entitled, ‘‘NRC Request for 

Information Concerning Patient Release 

Practices.’’ 

DATES: Submit comments by May 4, 

2015. Comments received after this date 

will be considered if it is practical to do 

so, but the Commission is able to ensure 

consideration only for comments 

received on or before this date. 

ADDRESSES: You may submit comments 

by any of the following methods: 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2015–0020. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–415–3463; 

email: Carol.Gallagher@nrc.gov. For 

technical questions, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

document. 

• Mail comments to: Tremaine 

Donnell, Office of Information Services, 

Mail Stop: T–5 F53, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: 

Tremaine Donnell, Office of Information 

Services, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–415–6258; email: 

INFOCOLLECTS.Resource@NRC.GOV. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2015– 

0020 when contacting the NRC about 

the availability of information for this 

action. You may obtain publiclyavailable information related to this 

action by any of the following methods: 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2015–0020. A copy 

of the collection of information and 

related instructions may be obtained 

without charge by accessing Docket ID 

NRC–2015–0020 on this Web site. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publiclyavailable documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. A copy 

of the collection of information and 

related instructions may be obtained 

without charge by accessing ADAMS 

Accession No. ML15015A612. The 

supporting statement and Patient 

Release Federal Register Notice 

Soliciting Information is available in 

ADAMS under Accession No. 

ML15015A624. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

• NRC’s Clearance Officer: A copy of 

the collection of information and related 

instructions may be obtained without 

charge by contacting NRC’s Clearance 

Officer, Tremaine Donnell, Office of 

Information Services, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001; telephone: 301–415– 

6258; email: INFOCOLLECTS.Resource@

NRC.GOV. 

B. Submitting Comments 

Please include Docket ID NRC–2015– 

0020 in the subject line of your 

comment submission, in order to ensure 

that the NRC is able to make your 

comment submission available to the 

public in this docket. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC posts all comment 

submissions at http://

mstockstill on DSK4VPTVN1PROD with NOTICES

11472 Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices 

www.regulations.gov as well as entering 

the comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment submissions into 

ADAMS. 

II. Background 

In accordance with the Paperwork 

Reduction Act of 1995 (44 U.S.C. 

Chapter 35), the NRC is requesting 

public comment on its intention to 

request the OMB’s approval for the 

information collection summarized 

below. 

1. The title of the information 

collection: NRC Request for Information 

Concerning Patient Release Practices. 

2. OMB approval number: OMB 

control number has not yet been 

assigned to this proposed information 

collection. 

3. Type of submission: New. 

4. The form number, if applicable: N/ 

A. 

5. How often the collection is required 

or requested: Once. 

6. Who will be required or asked to 

respond: Medical professional 

organizations, physicians, patients, 

patient advocacy groups, NRC and 

Agreement State medical use licensees, 

Agreement States, and other interested 

individuals who use, receive, license or 

have interest in the use of I–131 sodium 

iodine (hereafter referred to as ‘‘I–131’’) 

for the treatment of thyroid conditions. 

7. The estimated number of annual 

responses: A one-time collection 

estimated to have 1,180 responses (620 

medical community + 560 patients). 

8. The estimated number of annual 

respondents: 1,180 respondents (620 

medical community + 560 patients). 

9. The estimated number of hours 

needed annually to comply with the 

information collection requirement or 

request: 457.5 hours (255 medical 

community + 202.5 patients). 

10. Abstract: The NRC is requesting a 

one-time information collection that 

will be solicited in a Federal Register 

notice (FRN). The FRN will have 

specific I–131 patient release questions 

associated with: (1) Existing Web sites 

that the responders believe provide 

access to clear and consistent patient 

information about I–131 treatment 

processes and procedures; (2) 

information the responders believe 

represent best practices used in making 

informed decisions on releasing I–131 

patients and stand alone or 

supplemental voluntary patient/licensee 

guidance acknowledgment forms, if 

available; (3) an existing set of 

guidelines that the responder developed 

or received that provides instructions to 

released patients; and (4) an existing 

guidance brochure that the responder 

believes would be acceptable for 

nationwide distribution. The responses 

will form the basis for patient release 

guidance products developed in 

response to the NRC’s April 28, 2014, 

Staff Requirements—COMAMM–14– 

0001/COMWDM–14–0001— 

‘‘Background and Proposed Direction to 

NRC Staff to Verify Assumptions Made 

Concerning Patient Release Guidance.’’ 

The Commission, based on information 

from patients and patient advocacy 

groups, questioned the availability of 

clear, consistent, patient friendly and 

timely patient release information and 

directed the staff to work with a wide 

variety of stakeholders when developing 

new guidance products. This 

information collection effort was 

developed to gain input from as many 

stakeholders as possible. The NRC 

solicitation in the Federal Register is to 

obtain existing information from a 

variety of stakeholders. 

III. Specific Requests for Comments 

The NRC is seeking comments that 

address the following questions: 

1. Is the proposed collection of 

information necessary for the NRC to 

properly perform its functions? Does the 

information have practical utility? 

2. Is the estimate of the burden of the 

information collection accurate? 

3. Is there a way to enhance the 

quality, utility, and clarity of the 

information to be collected? 

4. How can the burden of the 

information collection on respondents 

be minimized, including the use of 

automated collection techniques or 

other forms of information technology? 

Dated at Rockville, Maryland, this 25th day 

of February, 2015. 

For the Nuclear Regulatory Commission. 

Tremaine Donnell, 

NRC Clearance Officer, Office of Information 

Services. 

[FR Doc. 2015–04318 Filed 3–2–15; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2015–0041] 

Biweekly Notice; Applications and 

Amendments to Facility Operating 

Licenses and Combined Licenses 

Involving No Significant Hazards 

Considerations 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Biweekly notice. 

SUMMARY: Pursuant to Section 189a. (2) 

of the Atomic Energy Act of 1954, as 

amended (the Act), the U.S. Nuclear 

Regulatory Commission (NRC) is 

publishing this regular biweekly notice. 

The Act requires the Commission to 

publish notice of any amendments 

issued, or proposed to be issued and 

grants the Commission the authority to 

issue and make immediately effective 

any amendment to an operating license 

or combined license, as applicable, 

upon a determination by the 

Commission that such amendment 

involves no significant hazards 

consideration, notwithstanding the 

pendency before the Commission of a 

request for a hearing from any person. 

This biweekly notice includes all 

notices of amendments issued, or 

proposed to be issued from February 5, 

2015 to February 18, 2015. The last 

biweekly notice was published on 

February 17, 2015. 

DATES: Comments must be filed by April 

2, 2015. A request for a hearing must be 

filed by May 4, 2015. 

ADDRESSES: You may submit comments 

by any of the following methods (unless 

this document describes a different 

method for submitting comments on a 

specific subject): 

• Federal Rulemaking Web site: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2015–0041. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–415–3463; 

email: Carol.Gallagher@nrc.gov. 

• Mail comments to: Cindy Bladey, 

Office of Administration, Mail Stop: 

OWFN–12–H08, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: 

Shirley Rohrer, Office of Nuclear 

Reactor Regulation, U.S. Nuclear 

Regulatory Commission, Washington DC 

20555–0001; telephone: 301–415–5411, 

email: Shirley.Rohrer@nrc.gov. 

mstockstill on DSK4VPTVN1PROD with NOTICES